High Vista Strategies LLC Amicus Therapeutics, Inc. Transaction History

High Vista Strategies LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$10.72 - $13.3 $157,937 - $195,948	-14,733 Reduced 19.06%	62,581 $786,000
Q4 2022 Feb 14, 2023	BUY	$9.89 - $12.7 $83,906 - $107,746	8,484 Added 12.33%	77,314 $944,000
Q3 2022 Nov 14, 2022	SELL	$9.82 - $12.75 $210,187 - $272,901	-21,404 Reduced 23.72%	68,830 $719,000
Q2 2022 Aug 15, 2022	SELL	$6.23 - $11.12 $112,283 - $200,415	-18,023 Reduced 16.65%	90,234 $969,000
Q1 2022 May 16, 2022	SELL	$7.89 - $12.48 $40,475 - $64,022	-5,130 Reduced 4.52%	108,257 $1.03 Million
Q3 2021 Nov 15, 2021	BUY	$8.74 - $11.84 $253,599 - $343,549	29,016 Added 34.39%	113,387 $1.08 Million
Q2 2021 Aug 16, 2021	BUY	$8.71 - $10.72 $734,871 - $904,457	84,371 New	84,371 $813,000
Q1 2021 May 17, 2021	SELL	$9.2 - $23.86 $365,920 - $949,007	-39,774 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$13.47 - $24.89 $92,687 - $171,268	6,881 Added 20.92%	39,774 $918,000
Q3 2020 Nov 16, 2020	BUY	$12.89 - $15.89 $77,726 - $95,816	6,030 Added 22.45%	32,893 $464,000
Q2 2020 Aug 14, 2020	BUY	$8.86 - $15.69 $238,006 - $421,480	26,863 New	26,863 $405,000

312

312M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.64B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on High Vista Strategies LLC with notifications on news.